BODIPY FL EDA free base

Epigenomic data analysis identifies genome-wide regulatory features that influence gene expression, chromatin state, and phenotype without changing the underlying DNA sequence. In this strategy, the core regulatory layer includes chromatin accessibility, transcription-factor or histone-mark occupancy, DNA methylation, and chromatin-state patterns; these features are measured by sequencing-based assays and interpreted as regulatory elements, promoters, enhancers, repressive domains, methylated cytosines, or candidate phenotype-associated chromatin programs. The literature links epigenomic features to phenotype by showing that functional genomic elements can be mapped across human cell types and tissues, and that integrated epigenomic maps reveal cell-type-specific regulatory programs. ENCODE integrated transcription, chromatin accessibility, transcription-factor occupancy, and histone modification data to annotate functional elements in the human genome, while the Roadmap Epigenomics Co

Southern blot is a DNA hybridization assay used to detect a defined DNA sequence within restriction-digested or otherwise fragmented genomic DNA. The method separates DNA fragments by agarose gel electrophoresis, transfers the size-resolved DNA pattern onto a solid support, denatures the DNA to permit base pairing, and detects fragments that hybridize with a complementary labeled probe; the readout is a band, smear, or fragment-size distribution corresponding to the target sequence and its restriction-fragment context. The assay reflects sequence presence, restriction fragment length, gene copy pattern, structural rearrangement, insertion or deletion affecting restriction sites, and some repeat-length or terminal restriction fragment applications when the experimental design links the probe to those genomic features. Classic applications include Southern blot-based telomere terminal restriction fragment analysis and minisatellite-based DNA fingerprinting, which illustrate how the same

The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.